# Radiolabeled Glass Beads Used for Treating Patients With Primary Liver Cancer When Surgery is Not an Option

> **NCT00740753** · NA · COMPLETED · sponsor: **OHSU Knight Cancer Institute** · enrollment: 339 (actual)

## Conditions studied

- Liver Cancer
- Hepatoma

## Interventions

- **DEVICE:** Yttrium 90 (TheraSphere)

## Key facts

- **NCT ID:** NCT00740753
- **Lead sponsor:** OHSU Knight Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-08
- **Primary completion:** 2021-04-28
- **Final completion:** 2021-04-28
- **Target enrollment:** 339 (ACTUAL)
- **Last updated:** 2022-09-30

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00740753

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00740753, "Radiolabeled Glass Beads Used for Treating Patients With Primary Liver Cancer When Surgery is Not an Option". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00740753. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*